HEADER LYASE 07-NOV-18 6I3U TITLE OPTIMIZATION OF POTENT AND SELECTIVE ATM INHIBITORS SUITABLE FOR A TITLE 2 PROOF-OF-CONCEPT STUDY IN HUNTINGTON'S DISEASE MODELS COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL 3-KINASE CATALYTIC SUBUNIT TYPE 3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PTDINS-3-KINASE TYPE 3,PHOSPHATIDYLINOSITOL 3-KINASE P100 COMPND 5 SUBUNIT,PHOSPHOINOSITIDE-3-KINASE CLASS 3,HVPS34; COMPND 6 EC: 2.7.1.137; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PIK3C3, VPS34; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ATM SURROGATE, VPS34, KINASE, HUNTINGTON'S DISEASE, LYASE EXPDTA X-RAY DIFFRACTION AUTHOR P.M.LEONARD REVDAT 4 24-JAN-24 6I3U 1 REMARK REVDAT 3 10-APR-19 6I3U 1 JRNL REVDAT 2 27-MAR-19 6I3U 1 JRNL REVDAT 1 20-MAR-19 6I3U 0 JRNL AUTH L.TOLEDO-SHERMAN,P.BRECCIA,R.CACHOPE,J.R.BATE, JRNL AUTH 2 I.ANGULO-HERRERA,G.WISHART,K.L.MATTHEWS,S.L.MARTIN,H.C.COX, JRNL AUTH 3 G.MCALLISTER,S.D.PENROSE,H.VATER,W.ESMIEU,A.VAN DE POEL, JRNL AUTH 4 R.VAN DE BOSPOORT,A.STRIJBOSCH,M.LAMERS,P.LEONARD, JRNL AUTH 5 R.E.JARVIS,W.BLACKABY,K.BARNES,M.EZNARRIAGA,S.DOWLER, JRNL AUTH 6 G.D.SMITH,D.F.FISCHER,O.LAZARI,D.YATES,M.ROSE,S.W.JANG, JRNL AUTH 7 I.MUNOZ-SANJUAN,C.DOMINGUEZ JRNL TITL OPTIMIZATION OF POTENT AND SELECTIVE ATAXIA JRNL TITL 2 TELANGIECTASIA-MUTATED INHIBITORS SUITABLE FOR A JRNL TITL 3 PROOF-OF-CONCEPT STUDY IN HUNTINGTON'S DISEASE MODELS. JRNL REF J.MED.CHEM. V. 62 2988 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 30840447 JRNL DOI 10.1021/ACS.JMEDCHEM.8B01819 REMARK 2 REMARK 2 RESOLUTION. 2.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.09 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 83.58 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 49365 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2561 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.09 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.14 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3470 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.92 REMARK 3 BIN R VALUE (WORKING SET) : 0.3420 REMARK 3 BIN FREE R VALUE SET COUNT : 174 REMARK 3 BIN FREE R VALUE : 0.3420 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4418 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 179 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.09000 REMARK 3 B22 (A**2) : -0.21000 REMARK 3 B33 (A**2) : -3.87000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.156 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.154 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.145 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.067 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4547 ; 0.007 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 4218 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6169 ; 1.447 ; 1.642 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9792 ; 1.306 ; 1.568 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 554 ; 6.031 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 237 ;35.464 ;22.996 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 796 ;16.008 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;21.156 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 587 ; 0.073 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5025 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 904 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2225 ; 3.057 ; 4.410 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2224 ; 3.054 ; 4.409 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2776 ; 4.433 ; 6.610 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2777 ; 4.433 ; 6.611 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2322 ; 4.013 ; 4.824 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2323 ; 4.012 ; 4.823 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3394 ; 6.184 ; 7.055 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5101 ; 7.591 ;51.630 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5072 ; 7.595 ;51.529 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6I3U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1200012769. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-APR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51984 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.090 REMARK 200 RESOLUTION RANGE LOW (A) : 83.580 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.09 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.13 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.82000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3LS8 REMARK 200 REMARK 200 REMARK: ROD-LIKE CRYSTALS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.4 M SODIUM MALONATE PH 7.0, 0.1 M REMARK 280 BIS-TRIS PROPANE PH 7.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 42.08500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 83.58500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.08500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 83.58500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1175 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 266 REMARK 465 MET A 267 REMARK 465 SER A 268 REMARK 465 LYS A 269 REMARK 465 HIS A 270 REMARK 465 HIS A 271 REMARK 465 GLU A 416 REMARK 465 PRO A 417 REMARK 465 THR A 418 REMARK 465 LYS A 419 REMARK 465 LYS A 420 REMARK 465 ASP A 421 REMARK 465 SER A 422 REMARK 465 GLN A 423 REMARK 465 SER A 424 REMARK 465 SER A 425 REMARK 465 VAL A 426 REMARK 465 SER A 427 REMARK 465 GLU A 428 REMARK 465 ASN A 429 REMARK 465 VAL A 430 REMARK 465 SER A 431 REMARK 465 ASN A 432 REMARK 465 SER A 433 REMARK 465 GLY A 434 REMARK 465 ILE A 435 REMARK 465 ASN A 436 REMARK 465 SER A 437 REMARK 465 ALA A 438 REMARK 465 GLU A 439 REMARK 465 SER A 452 REMARK 465 VAL A 453 REMARK 465 SER A 454 REMARK 465 SER A 455 REMARK 465 PRO A 456 REMARK 465 PRO A 457 REMARK 465 PRO A 458 REMARK 465 ALA A 459 REMARK 465 SER A 460 REMARK 465 LYS A 461 REMARK 465 THR A 462 REMARK 465 LYS A 463 REMARK 465 GLU A 464 REMARK 465 VAL A 465 REMARK 465 PRO A 466 REMARK 465 ASP A 467 REMARK 465 GLY A 468 REMARK 465 GLU A 469 REMARK 465 ASN A 470 REMARK 465 LEU A 471 REMARK 465 ALA A 873 REMARK 465 ALA A 874 REMARK 465 VAL A 875 REMARK 465 VAL A 876 REMARK 465 GLU A 877 REMARK 465 GLN A 878 REMARK 465 ILE A 879 REMARK 465 HIS A 880 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 272 CG CD CE NZ REMARK 470 LYS A 287 CG CD CE NZ REMARK 470 LYS A 328 CG CD CE NZ REMARK 470 LEU A 341 CG CD1 CD2 REMARK 470 LYS A 346 CD CE NZ REMARK 470 LYS A 354 CG CD CE NZ REMARK 470 LYS A 412 CE NZ REMARK 470 GLU A 472 CG CD OE1 OE2 REMARK 470 GLU A 502 CG CD OE1 OE2 REMARK 470 GLN A 508 CG CD OE1 NE2 REMARK 470 ARG A 561 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 566 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 567 CG CD CE NZ REMARK 470 LYS A 568 CE NZ REMARK 470 LYS A 624 CE NZ REMARK 470 LYS A 660 CG CD CE NZ REMARK 470 LYS A 678 CG CD CE NZ REMARK 470 GLU A 712 CG CD OE1 OE2 REMARK 470 ASN A 713 CG OD1 ND2 REMARK 470 LYS A 772 CG CD CE NZ REMARK 470 LYS A 801 CE NZ REMARK 470 LYS A 838 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1103 O HOH A 1125 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 279 104.00 -170.73 REMARK 500 ASP A 283 45.46 -101.75 REMARK 500 ARG A 566 -39.19 -39.76 REMARK 500 GLU A 596 82.68 -156.97 REMARK 500 ASP A 762 83.65 61.64 REMARK 500 PHE A 763 54.21 -99.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue H2E A 901 DBREF 6I3U A 268 880 UNP Q8NEB9 PK3C3_HUMAN 268 879 SEQADV 6I3U SER A 266 UNP Q8NEB9 EXPRESSION TAG SEQADV 6I3U MET A 267 UNP Q8NEB9 EXPRESSION TAG SEQADV 6I3U ALA A 612 UNP Q8NEB9 PHE 612 ENGINEERED MUTATION SEQADV 6I3U ASN A 616 UNP Q8NEB9 LEU 616 ENGINEERED MUTATION SEQADV 6I3U LEU A 634 UNP Q8NEB9 ILE 634 ENGINEERED MUTATION SEQADV 6I3U LEU A 682 UNP Q8NEB9 MET 682 ENGINEERED MUTATION SEQADV 6I3U TRP A 684 UNP Q8NEB9 PHE 684 ENGINEERED MUTATION SEQADV 6I3U GLY A 687 UNP Q8NEB9 INSERTION SEQRES 1 A 615 SER MET SER LYS HIS HIS LYS LEU ALA ARG SER LEU ARG SEQRES 2 A 615 SER GLY PRO SER ASP HIS ASP LEU LYS PRO ASN ALA ALA SEQRES 3 A 615 THR ARG ASP GLN LEU ASN ILE ILE VAL SER TYR PRO PRO SEQRES 4 A 615 THR LYS GLN LEU THR TYR GLU GLU GLN ASP LEU VAL TRP SEQRES 5 A 615 LYS PHE ARG TYR TYR LEU THR ASN GLN GLU LYS ALA LEU SEQRES 6 A 615 THR LYS PHE LEU LYS CYS VAL ASN TRP ASP LEU PRO GLN SEQRES 7 A 615 GLU ALA LYS GLN ALA LEU GLU LEU LEU GLY LYS TRP LYS SEQRES 8 A 615 PRO MET ASP VAL GLU ASP SER LEU GLU LEU LEU SER SER SEQRES 9 A 615 HIS TYR THR ASN PRO THR VAL ARG ARG TYR ALA VAL ALA SEQRES 10 A 615 ARG LEU ARG GLN ALA ASP ASP GLU ASP LEU LEU MET TYR SEQRES 11 A 615 LEU LEU GLN LEU VAL GLN ALA LEU LYS TYR GLU ASN PHE SEQRES 12 A 615 ASP ASP ILE LYS ASN GLY LEU GLU PRO THR LYS LYS ASP SEQRES 13 A 615 SER GLN SER SER VAL SER GLU ASN VAL SER ASN SER GLY SEQRES 14 A 615 ILE ASN SER ALA GLU ILE ASP SER SER GLN ILE ILE THR SEQRES 15 A 615 SER PRO LEU PRO SER VAL SER SER PRO PRO PRO ALA SER SEQRES 16 A 615 LYS THR LYS GLU VAL PRO ASP GLY GLU ASN LEU GLU GLN SEQRES 17 A 615 ASP LEU CYS THR PHE LEU ILE SER ARG ALA CYS LYS ASN SEQRES 18 A 615 SER THR LEU ALA ASN TYR LEU TYR TRP TYR VAL ILE VAL SEQRES 19 A 615 GLU CYS GLU ASP GLN ASP THR GLN GLN ARG ASP PRO LYS SEQRES 20 A 615 THR HIS GLU MET TYR LEU ASN VAL MET ARG ARG PHE SER SEQRES 21 A 615 GLN ALA LEU LEU LYS GLY ASP LYS SER VAL ARG VAL MET SEQRES 22 A 615 ARG SER LEU LEU ALA ALA GLN GLN THR PHE VAL ASP ARG SEQRES 23 A 615 LEU VAL HIS LEU MET LYS ALA VAL GLN ARG GLU SER GLY SEQRES 24 A 615 ASN ARG LYS LYS LYS ASN GLU ARG LEU GLN ALA LEU LEU SEQRES 25 A 615 GLY ASP ASN GLU LYS MET ASN LEU SER ASP VAL GLU LEU SEQRES 26 A 615 ILE PRO LEU PRO LEU GLU PRO GLN VAL LYS ILE ARG GLY SEQRES 27 A 615 ILE ILE PRO GLU THR ALA THR LEU ALA LYS SER ALA ASN SEQRES 28 A 615 MET PRO ALA GLN LEU PHE PHE LYS THR GLU ASP GLY GLY SEQRES 29 A 615 LYS TYR PRO VAL LEU PHE LYS HIS GLY ASP ASP LEU ARG SEQRES 30 A 615 GLN ASP GLN LEU ILE LEU GLN ILE ILE SER LEU MET ASP SEQRES 31 A 615 LYS LEU LEU ARG LYS GLU ASN LEU ASP LEU LYS LEU THR SEQRES 32 A 615 PRO TYR LYS VAL LEU ALA THR SER THR LYS HIS GLY PHE SEQRES 33 A 615 LEU GLN TRP ILE GLN GLY SER VAL PRO VAL ALA GLU VAL SEQRES 34 A 615 LEU ASP THR GLU GLY SER ILE GLN ASN PHE PHE ARG LYS SEQRES 35 A 615 TYR ALA PRO SER GLU ASN GLY PRO ASN GLY ILE SER ALA SEQRES 36 A 615 GLU VAL MET ASP THR TYR VAL LYS SER CYS ALA GLY TYR SEQRES 37 A 615 CYS VAL ILE THR TYR ILE LEU GLY VAL GLY ASP ARG HIS SEQRES 38 A 615 LEU ASP ASN LEU LEU LEU THR LYS THR GLY LYS LEU PHE SEQRES 39 A 615 HIS ILE ASP PHE GLY TYR ILE LEU GLY ARG ASP PRO LYS SEQRES 40 A 615 PRO LEU PRO PRO PRO MET LYS LEU ASN LYS GLU MET VAL SEQRES 41 A 615 GLU GLY MET GLY GLY THR GLN SER GLU GLN TYR GLN GLU SEQRES 42 A 615 PHE ARG LYS GLN CYS TYR THR ALA PHE LEU HIS LEU ARG SEQRES 43 A 615 ARG TYR SER ASN LEU ILE LEU ASN LEU PHE SER LEU MET SEQRES 44 A 615 VAL ASP ALA ASN ILE PRO ASP ILE ALA LEU GLU PRO ASP SEQRES 45 A 615 LYS THR VAL LYS LYS VAL GLN ASP LYS PHE ARG LEU ASP SEQRES 46 A 615 LEU SER ASP GLU GLU ALA VAL HIS TYR MET GLN SER LEU SEQRES 47 A 615 ILE ASP GLU SER VAL HIS ALA LEU PHE ALA ALA VAL VAL SEQRES 48 A 615 GLU GLN ILE HIS HET H2E A 901 37 HETNAM H2E 2-MORPHOLIN-4-YL-6-[7-[(2~{R})-1-MORPHOLIN-4-YLPROPAN- HETNAM 2 H2E 2-YL]OXY-9~{H}-THIOXANTHEN-4-YL]PYRAN-4-ONE FORMUL 2 H2E C29 H32 N2 O5 S FORMUL 3 HOH *179(H2 O) HELIX 1 AA1 ALA A 274 SER A 279 1 6 HELIX 2 AA2 GLY A 280 HIS A 284 5 5 HELIX 3 AA3 ASN A 289 TYR A 302 1 14 HELIX 4 AA4 THR A 309 PHE A 319 1 11 HELIX 5 AA5 PHE A 319 THR A 324 1 6 HELIX 6 AA6 ASN A 325 LYS A 328 5 4 HELIX 7 AA7 ALA A 329 CYS A 336 1 8 HELIX 8 AA8 LEU A 341 TRP A 355 1 15 HELIX 9 AA9 ASP A 359 LEU A 364 1 6 HELIX 10 AB1 GLU A 365 SER A 368 5 4 HELIX 11 AB2 ASN A 373 ARG A 385 1 13 HELIX 12 AB3 ASP A 388 LEU A 403 1 16 HELIX 13 AB4 LYS A 404 GLU A 406 5 3 HELIX 14 AB5 ASN A 407 ASN A 413 1 7 HELIX 15 AB6 ASP A 441 ILE A 445 5 5 HELIX 16 AB7 ASP A 474 ASN A 486 1 13 HELIX 17 AB8 ASN A 486 ASP A 503 1 18 HELIX 18 AB9 ASP A 503 ASP A 510 1 8 HELIX 19 AC1 ASP A 510 GLY A 531 1 22 HELIX 20 AC2 ASP A 532 ARG A 561 1 30 HELIX 21 AC3 ASN A 565 ASP A 579 1 15 HELIX 22 AC4 ASP A 579 ASN A 584 1 6 HELIX 23 AC5 PRO A 606 ALA A 609 5 4 HELIX 24 AC6 LEU A 641 GLU A 661 1 21 HELIX 25 AC7 VAL A 691 GLY A 699 1 9 HELIX 26 AC8 SER A 700 ALA A 709 1 10 HELIX 27 AC9 GLY A 714 ILE A 718 5 5 HELIX 28 AD1 SER A 719 GLY A 741 1 23 HELIX 29 AD2 ASN A 781 MET A 788 1 8 HELIX 30 AD3 SER A 793 ARG A 812 1 20 HELIX 31 AD4 TYR A 813 LEU A 823 1 11 HELIX 32 AD5 ILE A 829 LEU A 834 1 6 HELIX 33 AD6 GLU A 835 ASP A 837 5 3 HELIX 34 AD7 LYS A 838 PHE A 847 1 10 HELIX 35 AD8 SER A 852 PHE A 872 1 21 SHEET 1 AA1 4 ILE A 591 LEU A 593 0 SHEET 2 AA1 4 GLU A 596 ILE A 604 -1 O VAL A 599 N LEU A 593 SHEET 3 AA1 4 ALA A 619 THR A 625 -1 O LYS A 624 N GLY A 603 SHEET 4 AA1 4 THR A 610 LEU A 611 -1 N THR A 610 O GLN A 620 SHEET 1 AA2 6 ILE A 591 LEU A 593 0 SHEET 2 AA2 6 GLU A 596 ILE A 604 -1 O VAL A 599 N LEU A 593 SHEET 3 AA2 6 ALA A 619 THR A 625 -1 O LYS A 624 N GLY A 603 SHEET 4 AA2 6 LYS A 630 HIS A 637 -1 O PHE A 635 N ALA A 619 SHEET 5 AA2 6 HIS A 679 GLN A 683 -1 O LEU A 682 N LEU A 634 SHEET 6 AA2 6 VAL A 672 ALA A 674 -1 N LEU A 673 O PHE A 681 SHEET 1 AA3 3 VAL A 689 PRO A 690 0 SHEET 2 AA3 3 LEU A 750 LEU A 752 -1 O LEU A 752 N VAL A 689 SHEET 3 AA3 3 LEU A 758 HIS A 760 -1 O PHE A 759 N LEU A 751 SITE 1 AC1 14 LYS A 613 SER A 614 LYS A 636 LEU A 682 SITE 2 AC1 14 GLN A 683 TRP A 684 ILE A 685 SER A 688 SITE 3 AC1 14 PRO A 690 ILE A 761 HOH A1011 HOH A1020 SITE 4 AC1 14 HOH A1046 HOH A1090 CRYST1 84.170 167.170 61.500 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011881 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005982 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016260 0.00000